TPD52 and neoplasm: Conversely, renal cell carcinoma shows paradoxical tumor-suppressive activity; TPD52 downregulation is correlated with disease progression, while its restoration inhibits proliferation, EMT, and xenograft growth through PI3K/AKT pathway modulation [39].